The French pharma majorFR:SAN SNY reported net profit of 1.46 billion euros ($1.59 billion) for the quarter, on sales that grew to EUR10.73 billion from EUR9.99 billion in the previous year.
Read Full Story
Latest posts by Market Watch (see all)
- Dominion defamation suit against Fox News should go to trial: Delaware judge - March 31, 2023
- Personal Finance Daily: U.S. workers can’t keep their minds off work and don’t make these mistakes with your side hustle - March 31, 2023
- Google co-founder reportedly among those subpoenaed in JPMorgan-Epstein lawsuit - March 31, 2023
